You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

MTAP Deletion

Showing 1 - 25 of 198
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Mesothelioma, Non Small Cell Lung Cancer, Malignant Peripheral Nerve Sheath Tumors Trial in United States (MRTX1719)

Recruiting
  • Mesothelioma
  • +5 more
  • Denver, Colorado
  • +5 more
Aug 8, 2022

Solid Tumor Trial in United States (IDE397, Docetaxel, Paclitaxel)

Recruiting
  • Solid Tumor
  • Scottsdale, Arizona
  • +10 more
Jul 20, 2022

Locally Advanced Solid Tumor Trial (TNG462)

Not yet recruiting
  • Locally Advanced Solid Tumor
  • (no location specified)
Feb 17, 2023

Locally Advanced Solid Tumor Trial in United States (TNG908)

Recruiting
  • Locally Advanced Solid Tumor
  • Boston, Massachusetts
  • +7 more
Nov 13, 2022

Identify MTAP Loss in Advanced Solid Tumors or Lymphoma

Completed
  • Advanced Solid Tumors
  • Lymphoma
    • Boston, Massachusetts
    • +2 more
    Mar 13, 2020

    Esophageal Squamous Cell Carcinoma Trial (Combination (S095033 + paclitaxel))

    Not yet recruiting
    • Esophageal Squamous Cell Carcinoma
    • Combination (S095033 + paclitaxel)
    • (no location specified)
    Mar 28, 2022

    MTAP-null Non-Small-Cell Lung Cancer, MTAP-null Solid Tumors Trial (AMG 193, IDE397)

    Not yet recruiting
    • MTAP-null Non-Small-Cell Lung Cancer
    • MTAP-null Solid Tumors
    • (no location specified)
    Jul 27, 2023

    Advanced Solid Tumours That Are MTAP Deficient Trial in Spain, United States (AZD3470)

    Not yet recruiting
    • Advanced Solid Tumours That Are MTAP Deficient
    • New Haven, Connecticut
    • +3 more
    Nov 8, 2023

    Advanced MTAP-null Solid Tumors Trial in Worldwide (AMG 193, Docetaxel)

    Recruiting
    • Advanced MTAP-null Solid Tumors
    • Duarte, California
    • +17 more
    Aug 11, 2022

    Photoaging Trial (In a double-blinded fashion, 250 mg CANNAXR cream, Topical VEHICLE cream)

    Not yet recruiting
    • Photoaging
    • In a double-blinded fashion, 250 mg CANNAXR cream
    • Topical VEHICLE cream
    • (no location specified)
    Aug 23, 2022

    Urothelial Carcinoma, Metastatic Cancer Trial in Houston (Pemetrexed, Zimberelimab, Etrumadenant)

    Not yet recruiting
    • Urothelial Carcinoma
    • Metastatic Cancer
    • Houston, Texas
      MD Anderson Cancer Center
    Nov 28, 2022

    Examining Genetic Factors That Affect Severity of 22q11.2

    Recruiting
    • DiGeorge Syndrome
    • 22q11.2 Deletion Syndrome
      • New York, New York
      • +1 more
      Jul 18, 2022

      NSCLC (NSCLC) Trial in Japan, United States (Patritumab deruxtecan, Osimertinib)

      Recruiting
      • Non-Small Cell Lung Cancer (NSCLC)
      • Santa Monica, California
      • +13 more
      Feb 1, 2023

      Angelman Syndrome Trial (60 mg QD Alogabat, 40 mg QD Alogabat, 7 mg QD Alogabat)

      Not yet recruiting
      • Angelman Syndrome
      • 60 mg QD Alogabat
      • +4 more
      • (no location specified)
      Feb 1, 2023

      Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant, Infiltrating Bladder Urothelial Carcinoma With Glandular

      Recruiting
      • Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant
      • +6 more
      • Houston, Texas
        M D Anderson Cancer Center
      Nov 17, 2021

      Duchenne Muscular Dystrophy Trial in Worldwide (SRP-4045, SRP-4053, Placebo)

      Active, not recruiting
      • Duchenne Muscular Dystrophy
      • Phoenix, Arizona
      • +74 more
      Jan 17, 2023

      Leukemia, Lymphocytic, Chronic Trial in Germany (ibrutinib, obinutuzumab, venetoclax)

      Completed
      • Leukemia, Lymphocytic, Chronic
      • Dresden, Germany
      • +10 more
      Jan 13, 2023

      Chronic Lymphocytic Leukemia Trial in Worldwide (Venetoclax)

      Completed
      Has Results
      • Chronic Lymphocytic Leukemia
      • Louisville, Kentucky
      • +66 more
      Nov 9, 2022

      NSCLC Metastatic, NSCLC With Mutation in Epidermal Growth Factor Receptor Trial in Worldwide (Patritumab Deruxtecan (Fixed

      Active, not recruiting
      • Non-Small Cell Lung Cancer Metastatic
      • Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor Receptor
      • Patritumab Deruxtecan (Fixed dose)
      • Patritumab Deruxtecan (Up-Titration)
      • Gilbert, Arizona
      • +120 more
      Jan 12, 2023

      Metastatic Castration-resistant Prostate Cancer Trial in Salt Lake City (Bortezomib)

      Not yet recruiting
      • Metastatic Castration-resistant Prostate Cancer
      • Salt Lake City, Utah
        Huntsman Cancer Institute/University of Utah
      Sep 7, 2023

      Non Small Cell Lung Cancer Trial in Seoul (Lazertinib+Pemetrexed+Carboplatin, Lazertinib)

      Not yet recruiting
      • Non Small Cell Lung Cancer
      • Seoul, Korea, Republic of
        Yonsei University Health System, Severance Hospital
      Aug 31, 2023

      Healthy Trial in Philadelphia (Blood draw)

      Active, not recruiting
      • Healthy
      • Blood draw
      • Philadelphia, Pennsylvania
        The Clinical Translational Research Center (CTRC) at the Hospita
      Aug 16, 2022

      Partial PTEN Deletion in Breast Cancer

      Not yet recruiting
      • PTEN Gene Deletion
        • (no location specified)
        Oct 27, 2021

        Glioma (Diagnosis), Liquid Biopsy, Deep Learning Trial in Wuhan, Nanchang (Prediction of glioma grading and molecular subtype)

        Recruiting
        • Glioma (Diagnosis)
        • +2 more
        • Prediction of glioma grading and molecular subtype
        • Wuhan, Hubei, China
        • +1 more
        Sep 8, 2022

        Non Small Cell Lung Cancer Metastatic Trial in Worldwide (Osimertinib, Bevacizumab)

        Active, not recruiting
        • Non Small Cell Lung Cancer Metastatic
        • Dublin, Ireland
        • +24 more
        Aug 23, 2022